Aims and Scope
Journal of Developing Drugs, a broad-based journal was founded on two key tenets: To publish the most exciting researches with respect to the subject of Developing Drugs. Secondly, to provide a rapid turn-around time possible for reviewing and publishing, and to disseminate the articles freely for research, teaching and reference purposes.
In today's wired world information is available at the click of the button, curtsey the Internet. Journal of Developing Drugs-Open Access gives a worldwide audience larger than that of any subscription-based journal in Longdom field, no matter how prestigious or popular, and probably increases the visibility and impact of published work. Journal of Developing Drugs-Open Access gives barrier-free access to the literature for research. It increases convenience, reach, and retrieval power. Free online literature is available for software that facilitates full-text searching, indexing, mining, summarizing, translating, querying, linking, recommending, alerting, "mash-ups" and other forms of processing and analysis. Journal of Developing Drugs-Open Access puts rich and poor on an equal footing for these key resources and eliminates the need for permissions to reproduce and distribute content.
The journal informs the reader of new trends in Developing drugs and Clinical outcomes, patient safety, and programs for the development and effective, safe, and sustained use of medicines will be a feature of the journal. It also encourages and publishes articles that report novel findings in the following areas like Drug Development, Drug Designing, Drug Interactions, Drug Metabolism, Drug Monitoring, Drug Resistance, Drug Tampering, Drug delivery, drug discovery, Clinical Trials, Clinical Research, Surgical Infectious Diseases, Novel Drug Delivery Systems, Protein Aggregation, pharmaceutical drug, pre-clinical research, New chemical entities, Toxicity, Lead Optimization, Novel Drug Delivery, Polymer Based Drug Delivery, Molecular Drug Design, Drug Disposition, Computer Assisted Drug Design, New Drug Targets, Actions of Drugs, Drug Delivery Systems.
Journal of developing drugs is ardent to Open Access. We strongly believe that removing barriers to research published online will greatly aid to the progress in Longdom scientific and technical disciplines and will keep upto date with latest advances and reach the readers directly my mail for free of cost with immediate and permanent access to individual papers.
Journal of developing drugs accepts online letters to the editors, brief comments that contributes to the previously published articles or other relevant findings in Longdom field. Abstracts and full texts (HTML, PDF and XML format) of all articles published by Vitamins & Minerals are freely accessible to everyone immediately after publication. All works published by Longdom Publishing are under the terms of the Creative Commons Attribution License. This permits anyone to copy, distribute, transmit and adapt the work provided the original work and source is appropriately cited.
Definition of Open Access Publication
An Open Access Publication is one that meets the following two conditions:
- The author(s) and copyright holder(s) grant(s) to all users a free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, transmit and display the work publicly and to make and distribute derivative works, in any digital medium for any responsible purpose, subject to proper attribution of authorship, as well as the right to make small numbers of printed copies for their personal use.
- A complete version of the work and all supplemental materials, including a copy of the permission as stated above, in a suitable standard electronic format is deposited immediately upon initial publication in at least one online repository that is supported by an academic institution, scholarly society, government agency, or other well-established organization that seeks to enable Open Access, unrestricted distribution, interoperability, and long-term archiving (for the biomedical sciences, PubMed Central is such a repository).
As a member of Publisher International linking Association, PILA, Journal of Developing Drugs (of Longdom Publishing) follows the Creative Commons Attribution License and Scholars Open Access publishing policies.
Community standards, rather than copyright law, will continue to provide the mechanism for enforcement of proper attribution and responsible use of the published work, as they do now.